Association Between Hypnotic Use and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease and Insomnia

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD-2022. Global Initiative for Chronic Obstructive Lung Disease; 2022.
   Google Scholar
• Ahmad FB, Cisewski JA, Minino A, Anderson RN. Provisional Mortality Data - United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(14):519–522. doi:10.15585/mmwr.mm7014e1
   PubMed Web of Science ®Google Scholar
• Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): a Systematic Literature Review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–460. doi:10.2147/COPD.S234942
   PubMed Web of Science ®Google Scholar
• Valipour A, Lavie P, Lothaller H, Mikulic I, Burghuber OC. Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary disease. Sleep Med. 2011;12(4):367–372. doi:10.1016/j.sleep.2010.08.017
   PubMed Web of Science ®Google Scholar
• Budhiraja R, Parthasarathy S, Budhiraja P, Habib MP, Wendel C, Quan SF. Insomnia in patients with COPD. Sleep. 2012;35(3):369–375. doi:10.5665/sleep.1698
   PubMed Web of Science ®Google Scholar
• George CF, Bayliff CD. Management of insomnia in patients with chronic obstructive pulmonary disease. Drugs. 2003;63(4):379–387. doi:10.2165/00003495-200363040-00004
   PubMed Web of Science ®Google Scholar
• Stege G, Vos PJ, van den Elshout FJ, Richard Dekhuijzen PN, van de Ven MJ, Heijdra YF. Sleep, hypnotics and chronic obstructive pulmonary disease. Respir Med. 2008;102(6):801–814. doi:10.1016/j.rmed.2007.12.026
   PubMed Web of Science ®Google Scholar
• Luyster FS, Boudreaux-Kelly MY, Bon JM. Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs. Respir Res. 2023;24(1):93. doi:10.1186/s12931-023-02401-w
   PubMed Web of Science ®Google Scholar
• Kapella M, Steffen A, Prasad B, et al. Therapy for insomnia with chronic obstructive pulmonary disease: a randomized trial of components. J Clin Sleep Med. 2022;18(12):2763–2774. doi:10.5664/jcsm.10210
   PubMed Web of Science ®Google Scholar
• Hassinger AB, Bletnisky N, Dudekula R, El-Solh AA. Selecting a pharmacotherapy regimen for patients with chronic insomnia. Expert Opin Pharmacother. 2020;21(9):1035–1043. doi:10.1080/14656566.2020.1743265
   PubMed Web of Science ®Google Scholar
• Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol. 2002;22(3):285–293. doi:10.1097/00004714-200206000-00009
   PubMed Web of Science ®Google Scholar
• Kripke DF. Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry. 2007;7(42). doi:10.1186/1471-244X-7-42
   Google Scholar
• Berry SD, Lee Y, Cai S, Dore DD. Nonbenzodiazepine sleep medication use and Hip fractures in nursing home residents. JAMA Intern Med. 2013;173(9):754–761. doi:10.1001/jamainternmed.2013.3795
   PubMed Web of Science ®Google Scholar
• Donovan LM, Malte CA, Spece LJ, et al. Risks of Benzodiazepines in Chronic Obstructive Pulmonary Disease with Comorbid Posttraumatic Stress Disorder. Ann Am Thorac Soc. 2019;16(1):82–90. doi:10.1513/AnnalsATS.201802-145OC
   PubMed Web of Science ®Google Scholar
• Liao YH, Chen LY, Liao KM, Chen CY. Drug Safety of Benzodiazepines in Asian Patients With Chronic Obstructive Pulmonary Disease. Front Pharmacol. 2020;11:592910. doi:10.3389/fphar.2020.592910
   PubMed Web of Science ®Google Scholar
• Vincent BM, Wiitala WL, Burns JA, Iwashyna TJ, Prescott HC. Using Veterans Affairs Corporate Data Warehouse to identify 30-day hospital readmissions. Health Serv Outcomes Res Methodol. 2018;18(3):143–154. doi:10.1007/s10742-018-0178-3
   PubMed Web of Science ®Google Scholar
• Alexander M, Ray MA, Hebert JR, et al. The National Veteran Sleep Disorder Study: descriptive Epidemiology and Secular Trends, 2000-2010. Sleep. 2016;39(7):1399–1410. doi:10.5665/sleep.5972
   PubMed Web of Science ®Google Scholar
• Fischer MA, Stedman MR, Lii J, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284–290. doi:10.1007/s11606-010-1253-9
   PubMed Web of Science ®Google Scholar
• Bramoweth AD, Tighe CA, Berlin GS. Insomnia and Insomnia-Related Care in the Department of Veterans Affairs: an Electronic Health Record Analysis. Int J Environ Res Public Health. 2021;18(16):8573. doi:10.3390/ijerph18168573
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• Breiman L. Random forests. Mach Learn. 2001;45(1):5–32. doi:10.1023/A:1010933404324
   Web of Science ®Google Scholar
• Sohn MW, Arnold N, Maynard C, Hynes DM. Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metr. 2006;4(1):2. doi:10.1186/1478-7954-4-2
   PubMedGoogle Scholar
• Lorenz KA, Asch SM, Yano EM, Wang M, Rubenstein LV. Comparing strategies for United States veterans’ mortality ascertainment. Popul Health Metr. 2005;3(1):2. doi:10.1186/1478-7954-3-2
   PubMedGoogle Scholar
• Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Sturmer T. Variable selection for propensity score models. Am J Epidemiol. 2006;163(12):1149–1156. doi:10.1093/aje/kwj149
   PubMed Web of Science ®Google Scholar
• Seeger JD, Kurth T, Walker AM. Use of propensity score technique to account for exposure-related covariates: an example and lesson. Med Care. 2007;45(10 Supl 2):S143–148. doi:10.1097/MLR.0b013e318074ce79
   PubMed Web of Science ®Google Scholar
• Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515–526. doi:10.1093/biomet/81.3.515
   Web of Science ®Google Scholar
• Kripke DF, Klauber MR, Wingard DL, Fell RL, Assmus JD, Garfinkel L. Mortality hazard associated with prescription hypnotics. Biol Psychiatry. 1998;43(9):687–693. doi:10.1016/S0006-3223(97)00292-8
   PubMed Web of Science ®Google Scholar
• Sivertsen B, Madsen IE, Salo P, Tell GS, Overland S. Use of Sleep Medications and Mortality: the Hordaland Health Study. Drugs Real World Outcomes. 2015;2(2):123–128. doi:10.1007/s40801-015-0023-8
   PubMedGoogle Scholar
• Patorno E, Glynn RJ, Levin R, Lee MP, Huybrechts KF. Benzodiazepines and risk of all cause mortality in adults: cohort study. BMJ. 2017;358:j2941. doi:10.1136/bmj.j2941
   PubMed Web of Science ®Google Scholar
• Charlson F, Degenhardt L, McLaren J, Hall W, Lynskey M. A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol Drug Saf. 2009;18(2):93–103. doi:10.1002/pds.1694
   PubMed Web of Science ®Google Scholar
• Kripke DF, Langer RD, Kline LE. Hypnotics’ association with mortality or cancer: a matched cohort study. BMJ Open. 2012;2(1):e000850. doi:10.1136/bmjopen-2012-000850
   PubMed Web of Science ®Google Scholar
• Weich S, Pearce HL, Croft P, et al. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ. 2014;348:g1996. doi:10.1136/bmj.g1996
   PubMed Web of Science ®Google Scholar
• Lu X, Zhu J, Zhou X. The effect of benzodiazepines on insomnia in patients with chronic obstructive pulmonary disease: a meta-analysis of treatment efficacy and safety. Int J Chron Obstruct Pulmon Dis. 2016;2016(11):675–685.
   Google Scholar
• Chen SJ, Yeh CM, Chao TF, et al. The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: a Nationwide Population-Based Case-Control Study. Sleep. 2015;38(7):1045–1050. doi:10.5665/sleep.4808
   PubMed Web of Science ®Google Scholar
• Chung WS, Lai CY, Lin CL, Kao CH. Adverse Respiratory Events Associated With Hypnotics Use in Patients of Chronic Obstructive Pulmonary Disease: a Population-Based Case-Control Study. Medicine. 2015;94(27):e1110. doi:10.1097/MD.0000000000001110
   PubMed Web of Science ®Google Scholar
• Hawkins EJ, Malte CA, Grossbard JR, Saxon AJ. Prevalence and Trends of Concurrent Opioid Analgesic and Benzodiazepine Use Among Veterans Affairs Patients with Post-traumatic Stress Disorder, 2003-2011. Pain Medicine. 2015;16(10):1943–1954. doi:10.1111/pme.12787
   PubMed Web of Science ®Google Scholar
• Hawkins EJ, Goldberg SB, Malte CA, Saxon AJ. New Coprescription of Opioids and Benzodiazepines and Mortality Among Veterans Affairs Patients With Posttraumatic Stress Disorder. J Clin Psychiatry. 2019;80(4). doi:10.4088/JCP.18m12689
   PubMed Web of Science ®Google Scholar
• Hedstrom AK, Hossjer O, Trolle Lagerros Y, Akerstedt T. Short- and long-term mortality following hypnotic use. J Sleep Res. 2020;29(4):e13061. doi:10.1111/jsr.13061
   PubMed Web of Science ®Google Scholar
• Neutel CI, Johansen HL. Association between hypnotics use and increased mortality: causation or confounding? Eur J Clin Pharmacol. 2015;71(5):637–642. doi:10.1007/s00228-015-1841-z
   PubMed Web of Science ®Google Scholar
• Gomutbutra P, O’Riordan DL, Pantilat SZ. Management of moderate-to-severe dyspnea in hospitalized patients receiving palliative care. J Pain Symptom Manage. 2013;45(5):885–891. doi:10.1016/j.jpainsymman.2012.05.004
   PubMed Web of Science ®Google Scholar
• Psaty BM, Siscovick DS. Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction. JAMA. 2010;304(8):897–898. doi:10.1001/jama.2010.1205
   PubMed Web of Science ®Google Scholar
• Soyombo S, Stanbrook R, Aujla H, et al. Socioeconomic status and benzodiazepine and Z-drug prescribing: a cross-sectional study of practice-level data in England. Fam Pract. 2020;37(2):194–199. doi:10.1093/fampra/cmz054
   PubMed Web of Science ®Google Scholar
• Matkovic Z, Huerta A, Soler N, et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration. 2012;84(1):17–26. doi:10.1159/000335467
   PubMed Web of Science ®Google Scholar